This month we are excited to welcome Dr. Lorence Kim, M’00, W’00, to discuss the case of Moderna Therapeutics, the innovative pharmaceutical company harnessing the power of messenger RNA to enable in vivo production of therapeutic proteins. Prior to joining Moderna as Chief Financial Officer and member of the executive leadership team in 2014, Dr. Kim was co-head of the US biotechnology investment banking effort at Goldman Sachs where he was a member of the Healthcare Investment Banking Group for nearly fourteen years. Dr. Kim will be sharing his experience in setting a vision and implementing strategy for early and mid stage pharma companies, as well as the tactics required to raise capital and recruit partners.
Dr. Kim’s discussion will be followed by a reception with a dinner catered by Chipotle and drinks. Come mingle with fellow students from the entire Penn community, faculty, UPHS and Perelman leaders, and alumni.